Hyperandrogenemia: Clinical Trials

5 trials for Hyperandrogenemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 unknown, 1 active not recruiting, 1 terminated. 5 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable5Unknown 3, Active not recruiting 1, Terminated 1

Follow Hyperandrogenemia: new trials by email Literature Review of Hyperandrogenemia trials Research Report on Hyperandrogenemia

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluating the Influence of Diet-induced Weight Loss on Fat (Adipose) Tissue's Insulin Sensitivity and Testosterone Synthesis in Women With Overweight or Obesity, Insulin Resistance, and Hyperandrogenemia
Mediterranean-based, carbohydrate restricted, calorie reduced diet - Overweight and Obesity, Hyperandrogenemia
Not applicableActive not recruitingUniversity of Missouri-Columbia82024-01-072026-03-17
Effect of Spironolactone on Adrenal or Ovarian Androgen Production in Overweight Pubertal Girls With Androgen Excess
Spironolactone - Obesity, Hyperandrogenemia
Not applicableUnknownUniversity of Virginia202016-12-092023-10-27
Assessment of Sensitivity of the Hypothalamic GnRH Pulse Generator to Estradiol and Progesterone Inhibition
Progesterone, Estrace (estrogen) - Hyperandrogenemia, Polycystic Ovary Syndrome
Not applicableTerminatedUniversity of Virginia32011-04-222020-12-30
Evaluation of Adrenal Androgens in Normal and Obese Girls After Suppression and Stimulation
Dexamethasone, Cortrosyn - Hyperandrogenemia, Polycystic Ovary Syndrome
Not applicableUnknownUniversity of Virginia842006-10-102023-10-27
Assessment of the Sensitivity of the Hypothalamic GnRH Pulse Generator to Estradiol and Progesterone Inhibition
estrace, Progesterone - Hyperandrogenemia, Polycystic Ovary Syndrome (PCOS)
Not applicableUnknownUniversity of Virginia602000-04-012023-11-02

Narrower conditions

Polycystic Ovary Syndrome (4)  ·  Obesity (3)  ·  Insulin Resistance (1)  ·  Overweight (1)  ·  Weight Loss (1)

Broader conditions

Adnexal Diseases (4)  ·  Cysts (4)  ·  Endocrine System Diseases (4)  ·  Female Urogenital Diseases (4)  ·  Female Urogenital Diseases and Pregnancy Complications (4)  ·  Genital Diseases (4)  ·  Genital Diseases, Female (4)  ·  Gonadal Disorders (4)  ·  Neoplasms (4)  ·  Ovarian Cysts (4)  ·  Ovarian Diseases (4)  ·  Urogenital Diseases (4)  ·  Body Weight (3)  ·  Nutrition Disorders (3)  ·  Nutritional and Metabolic Diseases (3)

Interventions

Estradiol (2)  ·  Estrogens (2)  ·  Progesterone (2)  ·  Adrenocorticotropic Hormone (1)  ·  Cosyntropin (1)  ·  Dexamethasone (1)  ·  Spironolactone (1)

Sponsors

University of Virginia (4)  ·  University of Missouri-Columbia (1)

Countries

United States (5)

Top investigators

Christine Burt Solorzano, MD (2)  ·  Chris McCartney, MD (1)  ·  Elizabeth J Parks, PhD (1)  ·  Jean Ricci Goodman, MD (1)  ·  John C. Marshall, MD, PhD (1)

NIH funding

U54HD028934 (3), P50HD028934 (1)